BGI and Illumina's Business Model

About half of the volunteers in our study have been sequenced at fairly low what today would be considered fairly low coverage something called forex coverage. BGI got into a big business altercation with Illumina they felt they were being overcharged for reagents and so ended up buying a startup which competes against Illumina. They then suddenly became not a customer of Illumina but a competitor so then Illumina stopped working with them, it turned out to be a little bit of a disaster for BGI because it took them much longer than they thought to perfect the complete genomics technology. The CEO who led all this during the last few years has been removed the new CEO I think has a good